Member Info for OAPK20

What’s it say? For those not on X

4,960,000 At 20p expire 28/7/25

4,330,003 At 20p expire 22/5/26

9,290,003 To go less any converted since RNS.

And YES the CEO sold higher to convert warrants at 20p as did other Directors. As per PREVIOUS RNS publications.

Positive for who ? Those with the 8M or so warrants left to convert before 28th July or those waiting an entry price….

“ Sales from aggregates and other ancillary products and services continue to provide a stable revenue base as kiln commissioning progresses.

Advancing discussions with a leading Zambian bank to secure funding to increase interest in Limeco to 45% and repay Bridge Loan.

#FRG”

The drift continues…..

Limeco revenue estimates just for aggregate sales.

Oct 2024-Dec 2024 - approx $420,000 - $630,000 (FRG 10%?)

If now at full capacity of 350,000 tpa 2025 then Limeco Ave monthly revenue from aggregate potential approx $291,670 - $437,605. (FRG 16.5% then from May 20.5% potential increase to 44.5%)

Then quicklime sales now started…..

🧐 24 March 2025 -Hmmmmh?

Firering Strategic Minerals Plc

("Firering", the "Company" or the "Group") (AIM:FRG)

Result of Placing and Subscription; Related Party Transactions; TVR

Firering, an exploration company focusing on strategic minerals, announces that, further to its announcement of 4.34 p.m. (London time) on Friday 21 March 2025, it has successfully completed and closed the Placing and Subscription to raise gross proceeds of c£2.014 million.

Result of the Placing

A placing agreement was entered into by the Company, Shard Capital Partners LLP ("Shard") and Greenwood Capital Partners Limited on 21 March 2025. The Placing has raised, in aggregate, gross proceeds of c£1.537 million through the placing of 43,916,054 new ordinary shares of €0.001 each ("Ordinary Shares") to certain investors at a price of 3.5 pence per share ("Placing Price"). The Placing Price represents a discount of approximately 7.9 per cent. to the Closing Price of 3.8 pence per Ordinary Share on 20 March 2025, being the latest practicable business day prior to the publication of last Friday's announcement.

Result of the Subscription

In addition, the Company has raised, in aggregate, gross proceeds of £477,000 through the conditional placing of 13,628,570 new Ordinary Shares in a Subscription at the Placing Price.

However, due to the demand for the Placing Shares, the Company has utilised substantially all of its current headroom in satisfying the issue of Placing Shares.

The Subscription for the Subscription Shares is subject to approval by shareholders of a resolution to increase the Company's share capital authorities in general meeting. It is expected that such authority will be sought at the Company's 2025 Annual General Meeting following publication of the Annual Report for the year ended 31 December 2024, though the Directors reserve the right to convene a general meeting ahead of that point.

“ Stabilising production at Kiln 1 and generating revenue were the final key milestones required to progress discussions with a leading Zambian bank in relation to the previously agreed non-binding term sheet (see RNS dated 15 November 2024). With these milestones now achieved, discussions are advancing with the objective of securing funding that would enable Firering to increase its interest in Limeco to 45% and repay the outstanding Bridge Loan.”

And directors too

Someone still reducing perhaps.

@FireRing_SM

Our focus now is on steadily ramping up production to full capacity while ensuring the consistent delivery of high-quality quicklime to meet the growing demands of the Central African Copperbelt and Agricultural sectors.

Maybe fulfill the current ones first then expand

$9,060,000 annually for 151,000 homes at $5 a month recurring fee. ?

Confirmed sales then confirmed loan would be nice

Does he have warrants 🤔

Thought he was doing the house up 😜Telegram said so 😉

So why has it tanked recently?

(Greetings from 30,000 feet)... ✈️

For the record: Leakbot = One device. Complete Protection. No Competition.

(Oh, and we don't even bother mentioning the ones that strap on to old mechanical water meters in the pit near the road... good luck getting a wifi signal out there!)

#ONDO

Need to convert trials to deals and customers and revenue.

Does this sum things up?

1. Exposure to the Lithium Battery Supply Chain

• Atex Project (Côte d’Ivoire) is highly prospective for lithium (spodumene) and tantalum.

• The surging global demand for lithium, driven by electric vehicles and energy storage, makes early-stage lithium projects attractive.

• JV with Ricca Resources derisks capital expenditure as Ricca funds the project through DFS (Definitive Feasibility Study).

2. Cash Flow from Quicklime Production

• Limeco Project (Zambia) began production in early 2025.

• Quicklime is critical in copper mining—a major industry in Zambia—with local demand outstripping supply.

• Firering owns 20.5% of Limeco and has the option to increase to 75%. (45% ? )

• Targeting 600–800 tonnes/day output by end of 2025—this positions FRG as a near-term cash-generating business, uncommon among junior explorers.

3. Strategic, Non-Dilutive Financing Approach

• Rather than relying entirely on dilutive equity raises, FRG is:

• Pursuing Zambian bank debt for Limeco expansion. (under review by the bank’s senior investment committee)

• Receiving external funding (Ricca) for Atex development.

• This reduces shareholder dilution risk.

4. Upside Optionality in Tantalum and Other Critical Minerals

• Tantalum (co-product at Atex) is critical for electronics and aerospace.

• Additional pegmatite targets in Côte d’Ivoire may contain other valuable battery minerals.

Still flipping

If FDA asks GENI for new clinical data, revise previous results submitted , or update or resubmit parts of the application it could delay any approval by several months to a year.

Unless GENI have strong evidence to support their Supervisory Review they will need to comply with any additional FDA requests, and this will drag on costing more.

Either FDA say no, GENI withdraw or FDA agree with GENI current position and it’s approved (unlikely) or the process continues until final decision.

It’s being discussed elsewhere by traders. Hence the day trade pump (under different names)